AVR.AX Stock — Price, Charts & Analysis

Anteris Technologies Global Corp. (AVR.AX) has no trailing P/E shown and a forward P/E of -5.83x. This places AVR.AX in not enough valuation data territory based on the valuation data currently available on Worldtickers.

AVR.AX trades with -5.83x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether AVR.AX looks overvalued or undervalued.

AVR.AX's P/E of -5.83x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

AVR.AX's trailing EPS is -A$2.74 and forward EPS is -A$2.17.

EPS, or earnings per share, shows how much profit Anteris Technologies Global Corp. generated for each share. AVR.AX's trailing EPS is -A$2.74, and investors usually prefer EPS that is positive and growing over time.

Anteris Technologies Global Corp. has a market cap of A$1.23B, making AVR.AX a small-cap stock based on the current market value shown on Worldtickers.

AVR.AX's latest stock price on Worldtickers is A$12.63. The latest move is -A$0.87 or -6.44%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

AVR.AX's quote includes a latest price of A$12.63. The market open is A$13.01. Previous close is A$13.50. The intraday range is A$12.63 to A$13.13.

AVR.AX is down in the latest quote, with a move of -A$0.87 or -6.44%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

AVR.AX generated A$2.24M in trailing revenue. Revenue growth is 63.30%, which helps show whether demand is expanding or slowing.

AVR.AX's revenue growth is 63.30%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, AVR.AX does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -A$103.56M.

Gross margin is 74.98%. Margins show how efficiently Anteris Technologies Global Corp. turns revenue into profit.

Anteris Technologies Global Corp. carries A$3.32M and holds A$256.87M in cash.

AVR.AX holds A$256.87M on its balance sheet.

AVR.AX's book value per share is A$3.65.

Institutions hold 3.08% of AVR.AX shares. Insiders hold 0.16% of shares. Ownership mix helps investors understand how much of Anteris Technologies Global Corp. is held by professional investors and company insiders.

AVR.AX has 97.46M shares outstanding. Float shares are 65.79M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for AVR.AX, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for AVR.AX is -A$2.17. Revenue growth is 63.30%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

AVR.AX's trailing EPS is -A$2.74. Forward EPS is -A$2.17. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

AVR.AX is in the Healthcare sector. Its earnings multiple is -5.83x. Its latest displayed growth metric is 63.30%. Compare these figures with sector peers before deciding whether Anteris Technologies Global Corp. is stronger or weaker than average.

AVR.AX trades at A$12.63. The stock trades at -5.83x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Anteris Technologies Global Corp.'s fundamentals.

AVR.AX risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. No single stock should be evaluated without portfolio context.

AVR.AX should be compared with companies in Medical Devices. Its earnings multiple is -5.83x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Anteris Technologies Global Corp. (AVR.AX) operates in Healthcare, specifically Medical Devices. Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds tha

AVR.AX trades on ASX. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

AVR.AX stock is priced in AUD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Anteris Technologies Global Corp.'s official website listed on Worldtickers is anteristech.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Anteris Technologies Global Corp. employs about 174 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Anteris Technologies Global Corp. is headquartered in Toowong, QLD, Australia. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

AVR.AX is in the Healthcare sector and the Medical Devices industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

AVR.AX has traded between A$5.20 and A$15.47 over the past 52 weeks. At A$12.63, it is 18.36% below the high and 142.88% above the low. The 52-week range helps gauge long-term price momentum.

AVR.AX is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is A$12.82 and its 200-day moving average is A$9.43.

AVR.AX's RSI is 52.07. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

AVR.AX's latest RSI reading is 52.07, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for AVR.AX is near A$10.79. Key resistance is near A$13.60. Breaks above resistance or below support can change the short-term technical setup.

AVR.AX's nearest reported support level is A$10.79. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

AVR.AX's nearest reported resistance level is A$13.60. A breakout above resistance can improve momentum, especially when volume confirms the move.

AVR.AX trades about 20.19K shares daily on average. The latest displayed volume is 5.63K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

AVR.AX's MACD is 0.18, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

AVR.AX is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 52.07 (neutral). MACD is bullish. Nearest support is around A$10.79. Resistance is around A$13.60. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is A$12.07 (4.60% from price). MA50 is A$12.82 (-1.51% from price). MA200 is A$9.43 (33.96% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. AVR.AX's MA20 is A$12.07. MA50 is A$12.82. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

AVR.AX's pivot is near A$13.48. Support is near A$10.79. Resistance is near A$13.60. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for AVR.AX is near A$11.92. The next upper resistance zone is near A$13.78. These levels help define risk and possible follow-through zones after a breakout or breakdown.

AVR.AX's Bollinger range is roughly A$10.59 to A$13.56. Band width is near 24.66%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

AVR.AX's ATR-based typical daily range is about 4.32%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 5.63K shares. Average volume is about 20.19K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

AVR.AX's all-time high shown on Worldtickers is A$199.06. Its all-time low is A$1.63. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.